Analysts’ updated eps estimates for Wednesday, January 3rd:

Aaron’s (NYSE:AAN) had its buy rating reiterated by analysts at Stephens. The firm currently has a $61.00 target price on the stock.

Adobe Systems (NASDAQ:ADBE) had its buy rating reissued by analysts at Stephens. They currently have a $210.00 price target on the stock. The analysts wrote, “APDN and Colorcon have entered into a technology license memorandum of understanding that will combine DNA tagging with film coating for the pharmaceutical and nutraceutical industry.””

Ally Financial (NYSE:ALLY) had its sell rating reiterated by analysts at Stephens. The firm currently has a $27.00 target price on the stock.

Apricus Biosciences (NASDAQ:APRI) was upgraded by analysts at Zacks Investment Research from a strong sell rating to a hold rating. According to Zacks, “Apricus Bio operates in the pharmaceutical industry and focuses on research and development in the area of drug delivery. Its proprietary drug delivery technology is called NexACT ®. Backed by revenue generating CRO business, Bio-Quant, Inc. and its NexMed USA subsidiary, Apricus Bio has leveraged the flexibility of its proven NexACT® drug delivery technology to enable multi-route administration of new and improved compounds across numerous therapeutic classes. The Company is seeking to monetize its existing product pipeline, including compounds from pre-clinical through Phase 3, currently focused on dermatology, sexual dysfunction and cancer. Apricus Bio was formerly known as NexMed, Inc and is headquartered in San Diago, California. “

Blue Apron (NYSE:APRN) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Blue Apron Holdings, Inc. provides recipes and fresh ingredients for making home cooking accessible. It product consists of Blue Apron Meals, Blue Apron Wine, the Blue Apron Market and BN Ranch, a premium supplier of grass-fed beef and pasture-raised poultry. Blue Apron Holdings, Inc. is headquartered in New York. “

Antero Resources (NYSE:AR) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $22.00 target price on the stock. According to Zacks, “Antero Resources Corporation is an independent oil and natural gas company. It is primarily engaged in the exploitation, development and acquisition of unconventional oil and liquids-rich natural gas properties primarily located in the Appalachian Basin in West Virginia, Ohio and Pennsylvania. Antero Resources Corporation is headquartered in Denver, Colorado. “

Arcos Dorados (NYSE:ARCO) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Arcos Dorados Holdings Inc. operates as a franchisee of McDonald’s with its operations divided in Brazil; North Latin America division; South Latin America and the Caribbean division. It also runs quick service restaurants in Latin America and the Caribbean. It has operations in territories in Latin America and the Caribbean, including Argentina, Aruba, Brazil, Chile, Colombia, Costa Rica, Curaçao, Ecuador, French Guiana, Guadeloupe, Martinique, Mexico, Panama, Peru, Puerto Rico, Uruguay, the U.S. Virgin Islands of St. Croix and St. Thomas, and Venezuela. Arcos Dorados Holdings Inc. is headquartered in Buenos Aires, Argentina. “

Apollo Commercial Real Est. Finance (NYSE:ARI) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Apollo Commercial Real Estate Finance, Inc. is focused on investing in, acquiring and managing senior performing commercial real estate mortgage loans, commercial mortgage-backed securities, commercial real estate corporate debt and loans, and other real estate debt investments. The Company is a commercial real estate finance company that is managed and advised by ACREFI Management, LLC, a indirect subsidiary of Apollo Global Management, LLC. “

Arrow Financial (NASDAQ:AROW) had its hold rating reaffirmed by analysts at Sandler O’Neill.

Ascent Capital Group (NASDAQ:ASCMA) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Ascent Capital Group, Inc. is a holding company and its assets primarily consist of its wholly-owned subsidiary, Monitronics International, Inc. The Company provides security alarm monitoring and related services to residential and business subscribers throughout the United States and parts of Canada. Monitronics monitors signals arising from burglaries, fires and other events through security systems at subscribers’ premises. Ascent Capital Group, Inc., formerly known as Ascent Media Corporation, is based in Englewood, Colorado. “

Aspen Aerogels (NYSE:ASPN) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Aspen Aerogels, Inc. is an energy technology company that designs, develops and manufactures aerogel insulation used primarily in large-scale energy infrastructure facilities. The Company offers insulation for high temperature steam pipes, vessels, and equipment. Aspen serves petrochemical, refinery, industrial, and power generation sectors. It manufactures Cryogel (R), Pyrogel (R) and Spaceloft (R) products. Aspen Aerogels, Inc. is headquartered in Northborough, Massachusetts. “

Athene (NYSE:ATH) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Athene Holding Ltd. is a retirement services company. Its products and services include Fixed and fixed indexed annuity products, Reinsurance services offered to third-party annuity providers and Institutional products, such as funding agreements. Athene Holding Ltd. is based in Pembroke, Bermuda. “

AngloGold Ashanti (NYSE:AU) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $12.00 target price on the stock. According to Zacks, “AngloGold Limited is the largest gold producer at 7 million ounces a year, with reserves of 126 m oz. The company has operations in six countries on three continents, some of which are joint ventures, as well as exploration activities in ten countries. AngloGold can be financially characterized by high cash generation, substantial reinvestment in long-term growth and the payment of significant dividends. The company distinguishes itself from its producer peer group through its active involvement in the development of the gold market, particularly in Asia. “

Avinger (NASDAQ:AVGR) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $0.25 target price on the stock. According to Zacks, “Avinger, Inc. is engaged in designing, manufacturing and selling image-guided, catheter-based systems to treat peripheral arterial disease. The company’s product consists of Lightbox imaging console, Wildcat, Kittycat, Ocelot, Ocelot PIXL, Ocelot MVRX and Juicebox. Avinger, Inc. is based in Redwood City, California. “

Aviva (OTCMKTS:AVVIY) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Aviva has established a competitive position in North America. In the US, the world’s largest savings market, Aviva is the leading provider of indexed annuity and indexed life insurance products. Its principal activity is the provision of financial products and services, focused on the following lines of business: long-term insurance and savings business, fund management and general insurance and health. The company’s business is managed on a geographic basis through a regional management structure based on four regions, U.K., Europe, North America and Asia Pacific. The four regions function as five operating segments as, due to the size of the U.K. region, it is split into two operating segments, U.K. Life and U.K. General Insurance, which undertake long term insurance and savings business and general insurance respectively. “

Credicorp (NYSE:BAP) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $239.00 price target on the stock. According to Zacks, “CreditCorp LTD is a limited liability company to act as a holding company, to coordinate the policy and administration of its subsidiaries and engage in investing activities. Credicorp’s principal objective is to coordinate and manage the business plans of its subsidiaries in an effort to implement universal banking services in Peru, while diversifying regionally. They conduct their financial business exclusively through its subsidiaries “

Banco Bradesco (NYSE:BBD) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $12.00 target price on the stock. According to Zacks, “Banco Bradesco’s main activities are the provision of banking and insurance services such as private and industrial credit loans, credit cards, mortgaged loans, 24 hour banking, health and life insurance, leasing, pension fund management and services for stock market investors. “

Bioverativ (NASDAQ:BIVV) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Bioverativ Inc. is a biotechnology company. It focuses on the discovery, research, development, and commercialization of innovative therapies for the treatment of hemophilia and other blood disorders. Bioverativ Inc. is based in Waltham, United States. “

Builders FirstSource (NASDAQ:BLDR) had its buy rating reiterated by analysts at Seaport Global Securities. Seaport Global Securities currently has a $26.00 price target on the stock.

Brixmor Property Group (NYSE:BRX) was upgraded by analysts at Citigroup Inc to an overweight rating. They currently have $21.00 target price on the stock, up from their previous target price of $19.00. They noted that the move was a valuation call. The analysts noted that the move was a valuation call.

Credit Acceptance (NASDAQ:CACC) had its sell rating reiterated by analysts at Stephens. They currently have a $257.00 target price on the stock.

CIT Group (NYSE:CIT) had its buy rating reaffirmed by analysts at Stephens. They currently have a $60.00 target price on the stock.

CNH Industrial (NYSE:CNHI) had its buy rating reissued by analysts at Seaport Global Securities. The firm currently has a $16.00 price target on the stock.

America's Car-Mart (NASDAQ:CRMT) had its hold rating reiterated by analysts at Stephens. The firm currently has a $50.00 price target on the stock.

Essex Property Trust (NYSE:ESS) was upgraded by analysts at Citigroup Inc to an overweight rating. They currently have $278.00 price target on the stock, up from their previous price target of $253.00. They noted that the move was a valuation call. The analysts noted that the move was a valuation call.

German American Bancorp (NASDAQ:GABC) had its hold rating reissued by analysts at Hovde Group.

Gener8 Maritime (NYSE:GNRT) was downgraded by analysts at UBS Group AG from a buy rating to a neutral rating.

Horizon Bancorp (NASDAQ:HBNC) had its hold rating reaffirmed by analysts at Sandler O’Neill. They currently have a $29.50 price target on the stock.

J.B. Hunt Transport Services (NASDAQ:JBHT) had its buy rating reaffirmed by analysts at Stephens. Stephens currently has a $135.00 target price on the stock.

Martin Marietta Materials (NYSE:MLM) had its hold rating reaffirmed by analysts at Stephens. Stephens currently has a $250.00 price target on the stock.

Myriad Genetics (NASDAQ:MYGN) had its buy rating reiterated by analysts at Stephens. The analysts wrote, “We initiate coverage of Nightstar Therapeutics (NITE) with a Buy rating (PT$40), on the market opportunity likely addressed by NSR- REP1 in choroideremia (CHM). Choroideremia is a rare, inherited degenerative disease of the retina that typically has onsets in childhood or early adolescence. Patients then progress to reach legal or complete blindness in their 40s or 50s. There are currently no FDA-approved disease-modifying therapies for CHM. Nightstar’s lead asset, AAV-based gene therapy, NSR-REP1, is due to enter the 140-patient pivotal phase III STAR trial in 1H18 for the treatment of CHM. With the Lancet-published phase I/II data for NSR-REP1 in CHM, and subsequent updates from the multi-center program, Nightstar has been able to show that all NSR-REP1- treated patients who received the therapeutic dose were able to maintain vision to 5 years after treatment.””

NBT Bancorp (NASDAQ:NBTB) had its hold rating reaffirmed by analysts at Sandler O’Neill. They currently have a $38.00 target price on the stock.

Nicolet Bankshares (NASDAQ:NCBS) had its hold rating reaffirmed by analysts at Sandler O’Neill. They currently have a $58.50 price target on the stock.

PetMed Express (NASDAQ:PETS) had its buy rating reiterated by analysts at Northcoast Research. The firm currently has a $58.00 price target on the stock.

Seacoast Banking Corporation of Florida (NASDAQ:SBCF) had its hold rating reaffirmed by analysts at Hovde Group. They currently have a $27.00 price target on the stock.

Sterling Bancorp (NASDAQ:SBT) had its buy rating reiterated by analysts at Sandler O’Neill. The firm currently has a $14.50 target price on the stock.

Tractor Supply (NASDAQ:TSCO) had its buy rating reissued by analysts at Northcoast Research.

Vulcan Materials (NYSE:VMC) had its buy rating reissued by analysts at Stephens. The firm currently has a $158.00 target price on the stock.

Receive News & Ratings for Aaron's Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aaron's Inc and related companies with MarketBeat.com's FREE daily email newsletter.